H. Linde - MVZ Blut & Krebserkrankungen

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Routine care of patients with Multiple Myeloma (MM) 01/2019-12/2020 not suitable for high-dose melphalan therapy followed by autologous stem cell transplantation (ASCT)

R. Weide, J. Mohm, M. Klausmann,H. Linde, A. Rothe,T. Steinmetz,M. Hensel, P. Ehscheidt,M. Reiser, S. Doerfel,L. Mueller,B. Schmidt,

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

The ONCOReg Registry - Conclusions on tracking survival data over 23 years

M. Kersting, G. Innig, T. Goehler, V Petersen,H. Linde, S. Wilhelm, H. Eschenburg

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

Outcomes of patients with locally advanced or metastatic pancreatic cancer treated with different sequential treatment strategies - data from the prospective Tumour Registry Pancreatic Cancer

S. Hegewisch-Becker,M. Reiser,S. Doerfel,C. Lerchenmueller,H. Linde,T. Wolf, A. Binninger,N. Wetzel, M. Jaenicke, N. Marschner

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

Second primary malignancies (SPM) in treated and untreated patients with chronic lymphocytic leukemia (CLL): an analysis of the registry of the German CLL Study Group (GCLLSG)

M. Fuerstenau, T. Stumpf,A. -M. Fink, S. Robrecht, J. Bahlo, C. Maurer,H. Linde, L. Jacobasch, S. Doerfel, J. Lipke, A. Aldaoud,K. Fischer,

ONCOLOGY RESEARCH AND TREATMENT（2019）

引用0浏览0引用

CLL/NHL - patient registry OncoReg (Rituximab original vs. biosimilar)

H. Linde, C. Spohn, O. Rubanov, G. Innig, S. Mueller-Hagen, V. Petersen, R. Goettel, A. Nusch

ONCOLOGY RESEARCH AND TREATMENT（2019）

引用0浏览0引用

CLL - patient registry (Bendamustine original vs. generics)

H. Linde, K. Blumenstengel, T. Goehler, R. Goettel,M. -O. Zahn

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2018): 175-175

引用0浏览0引用

Two-year monitoring and treatment patterns in German patients with chronic-phase Chronic Myeloid Leukemia (CP-CML) in a prospective observational study

H. Tesch, A. Nusch,H. Linde, G. P. Sen, A. Schollmeyer, R. Hehlmann

ONCOLOGY RESEARCH AND TREATMENT（2018）

引用0浏览0引用

CLL - patient registry (overall dose of rituximab and gender)

H. Linde, K. Blumenstengel, T. Goehler, C. Spohn, R. Goettel, H. -W. Tessen

ONCOLOGY RESEARCH AND TREATMENT（2017）

引用0浏览0引用

DasPAQT: treating patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with Dasatinib: PCR-monitoring, adherence, quality of life, therapy satisfaction (OMC 2014-I; BMS CA180-565) - an analysis of 222 patients

H. Tesch,H. Pelz,H. Linde, C. Stosiek,I. Azeh,C. Schardt,L. Haeberle,E. Belleville,T. Steinmetz

ONCOLOGY RESEARCH AND TREATMENT（2017）

引用0浏览0引用

CLL - Patient registries confirm bendamustine-containing regimen (BR) as an effective first-line therapy

H. Linde, R. Goettel, H. -W. Tessen

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2016): 114.0-115.0

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn